A reliable limited sampling strategy for the estimation of mycophenolic acid area under the concentration time curve in adult renal transplant patients in the stable posttransplant period

Therapeutic Drug Monitoring

Volumn 32, Issue 2, 2010, Pages 136-140

  Mathew, Binu S ^a   Fleming, Denise H ^a   Annapandian, Vellaichamy M ^a   Prasanna, Samuel ^a   Prasanna, Chennaveera G ^a   Chandy, Sujith J ^a   John, George T ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Limited sampling strategy; Local formulation; Mycophenolate; Renal transplant

Indexed keywords

MOFILET; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; HUMAN; INDIA; KIDNEY TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RELIABILITY; SAMPLING; VALIDATION PROCESS; BLOOD; COMPARATIVE STUDY; MIDDLE AGED; PHYSIOLOGY; POSTOPERATIVE CARE; PROCEDURES; REPRODUCIBILITY; SAMPLE SIZE; STANDARDS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AREA UNDER CURVE; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE; YOUNG ADULT;

EID: 77950206350     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181cd550f     Document Type: Article

References (28)

1. Roth D, Colona J, Burke GW, et al. Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients. Transplantation. 1998;65:248-252.
2. Shaw LM, Nicholls A, Hale M, et al. Therapeutic monitoring of mycophenolic acid\a consensus panel report. Clin Biochem. 1998;31: 317-322.
3. Bullingham RES, Nicholls AJ, Kamm BR. Clinical pharmacokinetics of mycophenolate Mofetil. Clin Pharmacokinet. 1998;34:429-455.
4. Pawinski T, Durlik M, Szlaska I, et al. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first three months post transplant. J Clin Pharm Ther. 2006;31: 27-34.
5. Zicheng Y, Peijun Z, Da X, et al. Investigation on pharmacokinetics of mycophenolic acid in Chinese adult renal transplant patients. Br J Clin Pharmacol. 2006;62:446-452.
6. Shaw LM, Holt DW, Oellerich M, et al. Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Ther Drug Monit. 2001;23:305-315.
7. Van Gelder T, Hilbrands LB, Vanrenterghem Y, et al. A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation. 1999;68; 261-266.
8. Van Gelder T, Le Meur Y, Shaw LM, et al. Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Ther Drug Monit. 2006;28: 145-154.
9. Shaw LM, Kaplan B, De Nofrio D, et al. Pharmacokinetics and concentration control investigations of mycophenolic acid in adults after transplantation. Ther Drug Monit. 2000;22:14-19.
10. Pawinski T, Hale M, Korecka M, et al. Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus. Clin Chem. 2002; 48:1497-1504.
11. Filler G. Abbreviated mycophenolic acid AUC from CO, C1, C2, and C4 is preferable in children after renal transplantation on mycophe-nolate mofetil and tacrolimus therapy. Transplant Int. 2004;17: 120-125.
12. Zicheng Y, Weixia Z, Hao C, et al. Limited sampling strategy for the estimation of mycophenolic acid area under the plasma concentration time curve in adult patients undergoing liver transplant. Ther Drug Monit. 2007;29:207-214.
13. Weber LT, Hoecker B, Armstrong VW, et al. Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients. Ther Drug Monit. 2006;28: 623-631.
14. Ng J, Rogosheske J, Barker J, et al. A limited sampling model for estimation of total and unbound mycophenolic acid (MPA) area under the curve (AUC) in hematopoietic cell transplantation (HCT). Ther Drug Monit. 2006;28:394-401.
15. Cho EK, Han DJ, Kim SC, et al. Pharmacokinetic study of mycophenolic acid in Korean kidney transplant patients. J Clin Pharmacol. 2004;44: 743-750.
16. Weber LT, Schutz E, Lamersdorf T, et al. Pharmacokinetics of mycophenolic acid (MPA) and free MPA in paediatric renal transplant recipients\a multicentric study. Nephrol Dial Transplant. 1999;14: 33-34.
17. Lu XY, Huang HF, Sheng-Tu JZ, et al. Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patients. J Zhejiang Univ Sci B. 2005;6: 885-891.
18. Budde K, Tedesco Silva H, Medina Pestana J, et al. Enteric coated mycophenolate sodium provides higher mycophenolic acid predose levels compared with mycophenolate mofetil: implications for therapeutic drug monitoring. Ther Drug Monit. 2007;29:381-384.
19. Bullingham R, Shah J, Goldblum R, et al. Effects of food and antacid on the pharmacokinetics of single doses of mycophenolate mofetil in rheumatoid arthritis. Br J Clin Pharmacol. 1996;41:513-516.
20. Emcure Pharmaceuticals. Available at: www.emcure.co.in/products. html. Accessed December 1, 2009.
21. Fleming DH, Mathew BS, John GT, et al. A six-hour extrapolated sampling strategy for monitoring mycophenolic acid in renal transplant patients in the Indian Subcontinent. J Postgrad Med. 2006;52:248-252.
22. Suarez-Kurtz G, Bozza FA, Vicente FL, et al. Limited sampling strategy models for itraconzole and hydroxyl-itraconazole based on data from a bioequivalence study. Antimicrob Agents Chemother. 1999;43:134-140.
23. Wong KM, Shek CC, Chau KF, et al. Abbreviated tacrolimus area under the curve monitoring for renal transplant recipients. Am J Kidney Dis. 2000;35:660-666.
24. Suarez-Kurtz G, Riberio FM, Estrela RCE, et al. Limited sampling strategy models for estimating the pharmacokinetic parameters of 4- methylaminoantipyrine, an active metabolite of dipyrone. Braz J Med Biol Res. 2001;34:1475-1485.
25. Jeyaseelan L, Rao PSS. Statistical measurements of clinical agreement. Natl Med J India. 1992;5:286-290.
26. Xiao-Yang L, Hong-Feng H, Jian-Zhong ST, et al. Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patients. J Zhejiang Univ Sci. 2005;6B:885-891.
27. Patel CG, Harmon M, Gohh RY, et al. Concentration of myco-phenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus. Ther Drug Monit. 2007; 29:87-95.
28. Miura M, Satoh S, Niioka T, et al. Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients. Ther Drug Monit. 2008;30:52-59.